Clinical evaluation of cernilton in the treatment of the benign prostatic hypertrophy.
Clinical evaluation of Cernilton on benign prostatic hyperplasia.
A long-term therapeutic experience with Cernilton in chronic prostatitis.
Clinical evaluation of Cernilton on benign prostatic hypertrophy--a multiple center double-blind study with Paraprost.
A systematic review of Cernilton for the treatment of benign prostatic hyperplasia.
Treatment of outflow tract obstruction due to benign prostatic hyperplasia with the pollen extract,
cernilton.
Four drug varieties, namely, Finasteride, Tamsulosin, Doxazosin and
Cernilton dominate China's hospital-use anti-PH drug market.
Two studies tested a popular European rye-grass pollen extract called
Cernilton against a placebo in a total of 165 men for three to six months.
It contains
Cernilton, a standardised pollen extract from the rye grass family.
Another ingredient,
cernilton, from a natural bee pollen extract, is also well studied and one British double-blind, placebo controlled study found that
cernilton provided a significant improvement in BPH symptoms with a six-month course of treatment(ix).